Goldman Sachs
DH icon

Goldman Sachs’s Definitive Healthcare DH Stock Holding History

Goldman Sachs’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.95M Sell
5,959,143
-84,757
-1% -$77.6K ﹤0.01% 3885
2026
Q1 		$7.43M Buy
6,043,900
+101,949
+2% +$177K ﹤0.01% 3321
2025
Q4 		$17.1M Sell
5,941,951
-1,367,841
-19% -$3.79M ﹤0.01% 2539
2025
Q3 		$29.7M Sell
7,309,792
-1,432,475
-16% -$5.72M ﹤0.01% 1880
2025
Q2 		$34.1M Buy
8,742,267
+25,542
+0.3% +$80.5K ﹤0.01% 1640
2025
Q1 		$25.2M Buy
8,716,725
+7,404,363
+564% +$30M ﹤0.01% 1801
2024
Q4 		$5.39M Buy
1,312,362
+275,649
+27% +$1.21M ﹤0.01% 3378
2024
Q3 		$4.63M Buy
1,036,713
+1,845
+0.2% +$8.66K ﹤0.01% 3413
2024
Q2 		$5.65M Buy
1,034,868
+297,254
+40% +$1.87M ﹤0.01% 3039
2024
Q1 		$5.95M Sell
737,614
-9,574
-1% -$84.7K ﹤0.01% 2937
2023
Q4 		$7.43M Buy
747,188
+328,703
+79% +$2.58M ﹤0.01% 2792
2023
Q3 		$3.34M Buy
418,485
+331,956
+384% +$3.33M ﹤0.01% 3343
2023
Q2 		$952K Buy
86,529
+16,219
+23% +$167K ﹤0.01% 4369
2023
Q1 		$726K Buy
70,310
+2,224
+3% +$26.2K ﹤0.01% 4612
2022
Q4 		$748K Sell
68,086
-37,911
-36% -$487K ﹤0.01% 4619
2022
Q3 		$1.65M Buy
105,997
+75,859
+252% +$1.67M ﹤0.01% 4134
2022
Q2 		$691K Sell
30,138
-106,910
-78% -$2.29M ﹤0.01% 4866
2022
Q1 		$3.38M Buy
137,048
+89,327
+187% +$2.02M ﹤0.01% 3733
2021
Q4 		$1.3M Sell
47,721
-120,499
-72% -$4.22M ﹤0.01% 4621
2021
Q3 		$7.21M Buy
+168,220
New +$7.47M ﹤0.01% 3026

Other funds holding DH

AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs's DH Position: Q2 2026 in Review

Goldman Sachs reduced its Definitive Healthcare (DH) stake by 1.4% in Q2 2026, selling an estimated $77.6K and leaving 5,959,143 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

Goldman Sachs first reported a position in DH in Q3 2021 and has held it in 20 quarters since. The position peaked at $34.1M in Q2 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Goldman Sachs held 5,959,143 shares of Definitive Healthcare worth $4.95M as of Q2 2026.
  • Goldman Sachs sold 84,757 Definitive Healthcare shares in Q2 2026, an estimated $77.6K.
  • Definitive Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3885 holding.
  • Goldman Sachs first reported a position in Definitive Healthcare in Q3 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Definitive Healthcare position peaked at $34.1M in Q2 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.